Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal...

Area of Science:

• Oncology
• Genomics
• Immunology

Background:

• Natural killer/T-cell lymphoma, nasal type (NKTCL) is an aggressive lymphoma with limited therapeutic options.
• Understanding the molecular underpinnings of NKTCL is crucial for developing targeted therapies.

Purpose of the Study:

• To comprehensively analyze the molecular landscape of NKTCL using gene expression profiling and comparative genomic hybridization.
• To identify novel oncogenic pathways and potential therapeutic targets in NKTCL.

Main Methods:

• Combined gene expression profiling and array-based comparative genomic hybridization on NKTCL biopsies and cell lines.
• Comparison of NKTCL molecular profiles with peripheral T-cell lymphoma and normal NK cells.
• Protein level validation and in vitro drug sensitivity testing.

Main Results:

• NKTCL exhibits distinct gene expression profiles compared to other T-cell lymphomas, with higher levels of NK-cell and cytotoxic molecules.
• Overexpression of genes related to vascular biology, Epstein-Barr Virus, and PDGFRA was observed in NKTCL.
• Deregulation of AKT, JAK-STAT, and NF-κB pathways was confirmed, with several genes mapping to recurrent copy number aberrations.
• The tumor suppressor HACE1 was found to be deregulated in the frequently deleted 6q21 region.
• NKTCL cell lines showed sensitivity to imatinib, targeting PDGFRA.

Conclusions:

• NKTCL pathogenesis involves the perturbation of angiogenic pathways and deregulation of specific oncogenic signaling cascades.
• Emerging molecular pathways and identified targets, including PDGFRA and HACE1, offer promising avenues for NKTCL diagnosis and treatment.